...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Top-Line Primary Endpoint Results for Phase 3 BETonMACE Cardio Outcomes Trial were Announced September 30th ****Detailed Trial Data to be Presented at AHA Late Breaking Session Nov 16th & Company Webcast Nov 18th******

Message: New Share Price Contest update to Oct 12th

"$10 for the cardio, $10 for CKD, $10 for Cognition"

My thought process is similar Kipk. But I am conservatively assuming only cardio results will be announced by Nov 19th. I will be delighted to be wrong though!


New Message
Please login to post a reply